TipRanks on MSN9h
Beam Therapeutics presents additional data for BEAM-302 in AATDBeam Therapeutics (BEAM) presented additional data from the Phase 1/2 clinical trial of BEAM-302 in patients with alpha-1 antitrypsin deficiency, ...
A new therapy that first made headlines in 2021 is now showing potential to heal human cartilage. Developed by scientists at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback